These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 191471)

  • 1. Metabolism of vasoactive peptides by human endothelial cells in culture. Angiotensin I converting enzyme (kininase II) and angiotensinase.
    Johnson AR; Erdös EG
    J Clin Invest; 1977 Apr; 59(4):684-95. PubMed ID: 191471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bradykinin degrading activity in cultured human endothelial cells.
    Graf K; Gräfe M; Auch-Schwelk W; Baumgarten CR; Bossaller C; Fleck E
    J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S16-20. PubMed ID: 1282624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human pulmonary endothelial cells in culture. Activities of cells from arteries and cells from veins.
    Johnson AR
    J Clin Invest; 1980 Apr; 65(4):841-50. PubMed ID: 6987268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The angiotensin I converting enzyme.
    Erdös EG
    Fed Proc; 1977 Apr; 36(5):1760-5. PubMed ID: 191298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial angiotensin-converting enzyme and neutral endopeptidase in isolated human umbilical vein: an effective bradykinin inactivation pathway.
    Nowak W; Errasti AE; Armesto AR; Santín Velazque NL; Rothlin RP
    Eur J Pharmacol; 2011 Sep; 667(1-3):271-7. PubMed ID: 21651905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin converting enzyme and kininase-II-like activities in cultured valvular interstitial cells of the rat heart.
    Katwa LC; Ratajska A; Cleutjens JP; Sun Y; Zhou G; Lee SJ; Weber KT
    Cardiovasc Res; 1995 Jan; 29(1):57-64. PubMed ID: 7895240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The novel gaseous vasorelaxant hydrogen sulfide inhibits angiotensin-converting enzyme activity of endothelial cells.
    Laggner H; Hermann M; Esterbauer H; Muellner MK; Exner M; Gmeiner BM; Kapiotis S
    J Hypertens; 2007 Oct; 25(10):2100-4. PubMed ID: 17885553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin I-converting enzyme in amniotic fluid.
    Yasui T; Alhenc-Gelas F; Corvol P; Menard J
    J Lab Clin Med; 1984 Nov; 104(5):741-51. PubMed ID: 6092499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of angiotensin-converting enzyme activity in cultured pulmonary artery endothelial cells.
    Del Vecchio PJ; Smith JR
    J Cell Physiol; 1981 Sep; 108(3):337-45. PubMed ID: 6270164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of kinins and angiotensins in the isolated glomerulus and brush border of rat kidney.
    Ward PE; Schultz W; Reynolds RC; Erdös EG
    Lab Invest; 1977 Jun; 36(6):599-606. PubMed ID: 194111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Properties and action specificity of carboxycathepsin (peptidyl dipepsidase) from bovine kidneys].
    Eliseeva IuE; Orekhovich VN; Pavlikhina LV
    Vopr Med Khim; 1976; 22(1):81-9. PubMed ID: 193290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of pathophysiologic state on the metabolism of vasoactive peptides by mammalian lung.
    Stalcup SA; Leuenberger P; Greenbaum LM; Mellins RB; Turino GM
    Bull Eur Physiopathol Respir; 1979; 15(5):1031-44. PubMed ID: 228783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on bradykinin-binding cell fractions. 1. Characterization of kininase activity of the microsomal and membrane fraction from the rat uterus].
    Jankova T; Paegelow I; Reissmann S; Arold H
    Acta Biol Med Ger; 1975; 34(1):9-13. PubMed ID: 241185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin I-converting enzyme inhibitor peptides derived from the endostatin-containing NC1 fragment of human collagen XVIII.
    Farias SL; Sabatini RA; Sampaio TC; Hirata IY; Cezari MH; Juliano MA; Sturrock ED; Carmona AK; Juliano L
    Biol Chem; 2006 May; 387(5):611-6. PubMed ID: 16740133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release of angiotensin I-converting enzyme by endothelial cells in vitro.
    Noveral JP; Mueller SN; Levine EM
    J Cell Physiol; 1987 Apr; 131(1):1-5. PubMed ID: 3032989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A ligand-based approach to investigate the expression and function of angiotensin converting enzyme in intact human umbilical vein endothelial cells.
    Koumbadinga GA; Bawolak MT; Marceau E; Adam A; Gera L; Marceau F
    Peptides; 2010 Aug; 31(8):1546-54. PubMed ID: 20452384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme is involved in outside-in signaling in endothelial cells.
    Kohlstedt K; Brandes RP; Müller-Esterl W; Busse R; Fleming I
    Circ Res; 2004 Jan; 94(1):60-7. PubMed ID: 14615289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipopolysaccharides decrease angiotensin converting enzyme activity expressed by cultured human endothelial cells.
    Watanabe K; Lam G; Keresztes RS; Jaffe EA
    J Cell Physiol; 1992 Feb; 150(2):433-9. PubMed ID: 1310327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of new peptide inhibitors on the ratio of angiotensin I-converting and kinin-degrading activities of dipeptidyl carboxypeptidase (angiotensin-converting enzyme).
    Kalinina EV; Posdnev VF; Komissarova NV; Gomazkov OA
    Biochemistry (Mosc); 1997 Mar; 62(3):247-50. PubMed ID: 9275297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of angiotensin converting enzyme activity in cultured endothelial cells by hypoxia.
    Stalcup SA; Lipset JS; Woan JM; Leuenberger P; Mellins RB
    J Clin Invest; 1979 May; 63(5):966-76. PubMed ID: 221532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.